These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27114608)

  • 41. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism.
    Piana A; Orrù M; Masia MD; Sotgiu G; Muresu E; Maida A
    New Microbiol; 2003 Oct; 26(4):375-81. PubMed ID: 14596348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.
    Amaya-Tapia G; Martín-Del Campo L; Aguirre-Avalos G; Portillo-Gómez L; Covarrubias-Pinedo A; Aguilar-Benavides S
    Microb Drug Resist; 2000; 6(2):143-5. PubMed ID: 10990269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of bacteriophage type of Mycobacterium tuberculosis: absence of variation caused by experimental chemotherapy in mice and analysis of spontaneous variation.
    Clavel S; Clement F
    Am Rev Respir Dis; 1977 Mar; 115(3):443-7. PubMed ID: 402876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
    Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation.
    Dorhoi A; Kaufmann SH
    Eur J Immunol; 2015 Aug; 45(8):2191-202. PubMed ID: 26140356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.
    Urdahl KB
    Semin Immunol; 2014 Dec; 26(6):578-87. PubMed ID: 25453230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
    Nikonenko BV; Samala R; Einck L; Nacy CA
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4550-5. PubMed ID: 15561824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.
    Matt U; Selchow P; Dal Molin M; Strommer S; Sharif O; Schilcher K; Andreoni F; Stenzinger A; Zinkernagel AS; Zeitlinger M; Sander P; Nemeth J
    Int J Antimicrob Agents; 2017 Jul; 50(1):55-62. PubMed ID: 28506804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for
    Laval T; Pedró-Cos L; Malaga W; Guenin-Macé L; Pawlik A; Mayau V; Yahia-Cherbal H; Delos O; Frigui W; Bertrand-Michel J; Guilhot C; Demangel C
    Elife; 2021 Dec; 10():. PubMed ID: 34951591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis.
    Vandal OH; Pierini LM; Schnappinger D; Nathan CF; Ehrt S
    Nat Med; 2008 Aug; 14(8):849-54. PubMed ID: 18641659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iron limitation in M. tuberculosis has broad impact on central carbon metabolism.
    Theriault ME; Pisu D; Wilburn KM; Lê-Bury G; MacNamara CW; Michael Petrassi H; Love M; Rock JM; VanderVen BC; Russell DG
    Commun Biol; 2022 Jul; 5(1):685. PubMed ID: 35810253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide screen for Mycobacterium tuberculosis genes that regulate host immunity.
    Beaulieu AM; Rath P; Imhof M; Siddall ME; Roberts J; Schnappinger D; Nathan CF
    PLoS One; 2010 Dec; 5(12):e15120. PubMed ID: 21170273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB.
    Bryk R; Mundhra S; Jiang X; Wood M; Pfau D; Weber E; Park S; Zhang L; Wilson C; Van der Westhuyzen R; Street L; Chibale K; Zimmerman M; Dartois V; Pastore N; Ballabio A; Hawryluk N; Canan S; Khetani V; Camardo J; Nathan C
    PLoS Pathog; 2020 Jun; 16(6):e1008567. PubMed ID: 32574211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.
    Gold B; Pingle M; Brickner SJ; Shah N; Roberts J; Rundell M; Bracken WC; Warrier T; Somersan S; Venugopal A; Darby C; Jiang X; Warren JD; Fernandez J; Ouerfelli O; Nuermberger EL; Cunningham-Bussel A; Rath P; Chidawanyika T; Deng H; Realubit R; Glickman JF; Nathan CF
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16004-11. PubMed ID: 23012453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Sculpting of the Mycobacterium tuberculosis Genome by Host Cell-Derived Pressures.
    Russell DG; Lee W; Tan S; Sukumar N; Podinovskaia M; Fahey RJ; Vanderven BC
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 25584198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic nucleotide signaling in Mycobacterium tuberculosis: an expanding repertoire.
    Johnson RM; McDonough KA
    Pathog Dis; 2018 Jul; 76(5):. PubMed ID: 29905867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice.
    Gandotra S; Schnappinger D; Monteleone M; Hillen W; Ehrt S
    Nat Med; 2007 Dec; 13(12):1515-20. PubMed ID: 18059281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.